We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KBWY icon
2376
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$305M
$106K ﹤0.01%
+4,584
New +$105K
NHI icon
2377
National Health Investors
NHI
$3.61B
$106K ﹤0.01%
1,572
-9,058
-85% -$632K
PRTA icon
2378
Prothena Corp
PRTA
$442M
$106K ﹤0.01%
2,068
+140
+7% +$4.37K
RBCAA icon
2379
Republic Bancorp
RBCAA
$1.92B
$106K ﹤0.01%
2,292
+810
+55% +$37K
KAI icon
2380
Kadant
KAI
$3.91B
$105K ﹤0.01%
597
-637
-52% -$112K
DCPH
2381
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$105K ﹤0.01%
2,852
-1,893
-40% -$73.3K
MDC
2382
DELISTED
M.D.C. Holdings, Inc.
MDC
$105K ﹤0.01%
2,075
-8,377
-80% -$480K
BE icon
2383
Bloom Energy
BE
$63.6B
$104K ﹤0.01%
3,862
-30,353
-89% -$736K
FCNCA icon
2384
First Citizens BancShares
FCNCA
$25.4B
$104K ﹤0.01%
125
+23
+23% +$19.6K
FOSL icon
2385
Fossil Group
FOSL
$323M
$104K ﹤0.01%
7,274
-3,332
-31% -$43.9K
IBRX icon
2386
ImmunityBio
IBRX
$8.07B
$104K ﹤0.01%
7,269
+5,630
+344% +$93K
OII icon
2387
Oceaneering
OII
$4.98B
$104K ﹤0.01%
6,684
-1,928
-22% -$26.9K
RRGB icon
2388
Red Robin
RRGB
$151M
$104K ﹤0.01%
3,161
+2,346
+288% +$80K
RSP icon
2389
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$104K ﹤0.01%
692
+527
+319% +$78.5K
SBGI icon
2390
Sinclair Inc
SBGI
$1.05B
$104K ﹤0.01%
3,150
-1,622
-34% -$52.5K
TALO icon
2391
Talos Energy
TALO
$2.57B
$104K ﹤0.01%
6,698
-358
-5% -$4.95K
TWLO icon
2392
Twilio
TWLO
$38B
$104K ﹤0.01%
264
-15,592
-98% -$5.41M
CMRX
2393
DELISTED
Chimerix, Inc.
CMRX
$104K ﹤0.01%
12,968
-5,464
-30% -$45.4K
AXSM icon
2394
Axsome Therapeutics
AXSM
$11.2B
$103K ﹤0.01%
1,536
-2,586
-63% -$155K
CAN
2395
Canaan Creative
CAN
$155M
$103K ﹤0.01%
12,554
-63,665
-84% -$723K
SENEA icon
2396
Seneca Foods Class A
SENEA
$1.2B
$103K ﹤0.01%
2,032
-645
-24% -$31.1K
TRUE
2397
DELISTED
TrueCar
TRUE
$103K ﹤0.01%
18,201
+10,367
+132% +$52.2K
TWO
2398
Two Harbors Investment
TWO
$1.27B
$103K ﹤0.01%
3,406
-6,067
-64% -$181K
RSX
2399
DELISTED
VanEck Russia ETF
RSX
$103K ﹤0.01%
3,545
-9,154
-72% -$251K
NBEV
2400
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$103K ﹤0.01%
46,228
+27,135
+142% +$63.2K
94 95
96
97 98

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.